Top 12 manufacturers in Right Ventricular Assist Systems (RVAS) Market
Updated 11:20:41 December 02, 2019
Prof Resear published a new Market report on Right Ventricular Assist Systems (RVAS) Market. It present the largest 12 manufacruers in Right Ventricular Assist Systems (RVAS) Market. The report is a professional and in-depth study on the current state of the global Right Ventricular Assist Systems (RVAS) market with a focus on the Chinese market. The report provides key statistics on market of Right Ventricular Assist Systems (RVAS). It is a valuable source of guidance and direction for companies and individuals interested in Right Ventricular Assist Systems (RVAS) industry.
.
Baxter International
Ref A: 9440D93758964E5EB929F438776D3786 Ref B: SJCEDGE0222 Ref C: 2019-12-02T03:20:02Z
Inc. (USA)
Ref A: C4F237A9950F4D709AA89CA8EA10D9AF Ref B: SJCEDGE0217 Ref C: 2019-12-02T03:20:03Z
Abbott Diabetes Care
Ref A: 400859DD26C849CFAC4141DEFC533F96 Ref B: SJCEDGE0408 Ref C: 2019-12-02T03:20:06Z
Inc. (USA)
Ref A: DC16E6AE5BAF4B1C877A242547B14750 Ref B: SJCEDGE0411 Ref C: 2019-12-02T03:20:07Z
Vital Therapies
Vital Therapies , Inc., a biotherapeutic company, focuses on developing cell-based therapies for the treatment of acute forms of liver failure. Vital Therapies , Inc. was founded in 2003 and is based in San Diego, California. Vital Therapies operates under Biotechnology classification in USA and is traded on NASDAQ. It employs 10 people. Apr 12, 2019 · Vital Therapies is a biotherapeutic company developing a cell-based system for the treatment of acute forms of liver failure. The Company’s lead product candidate, the ELAD® System, is a human cell-based, bio-artificial liver support system currently in Phase III clinical trials. Sep 23, 2018 · Glassdoor gives you an inside look at what its like to work at Vital Therapies , including salaries, reviews, office photos, and more. This is the Vital Therapies company profile . All content is posted anonymously by employees working at Vital Therapies .
Inc. (USA)
Ref A: AFFBC6A4571D4331B236589F0BEAF99F Ref B: SJCEDGE0221 Ref C: 2019-12-02T03:20:11Z
Xenios AG (Germany)
Xenios AG – a Fresenius Medical Care company – is a pioneer in extracorporeal heart & lung support. Our dedication to improve patients’ lives, drives us to constantly develop high-quality products and application-related service excellence, which allow to replace standard therapies with superior extracorporeal solutions. XENIOS AG provides medical devices. The Company develops extracorporeal therapy systems such as artificial lungs , blood pumps, vascular access devices, … The Xenios AG Code of Conduct provides useful guidance for the holding and the single companies or therapy brands (Novalung, Medos). As required by both United States and French laws, U.S. Sunshine Act and Loi Bertrand, Xenios AG publicly discloses its interactions with both U.S. and French health care professionals .
Asahi Kasei Medical Co.
Ref A: 42F2BA9350034D729A6A1BB0476F81DE Ref B: SJCEDGE0416 Ref C: 2019-12-02T03:20:16Z
Ltd. (Japan)
Ref A: 1F63A7948BBA47069284E3586B1255A4 Ref B: SJCEDGE0215 Ref C: 2019-12-02T03:20:19Z
Medtronic
Ref A: B63A0E10B25B4F589BF1070F59A98086 Ref B: SJCEDGE0213 Ref C: 2019-12-02T03:20:25Z
Inc. (USA)
Ref A: 6C3FA786E13041DE9404E1AB06F4D43B Ref B: SJCEDGE0407 Ref C: 2019-12-02T03:20:27Z
HeartWare Internatio
Ref A: 0375AC665C804514BC61DC4132A736AB Ref B: SJCEDGE0220 Ref C: 2019-12-02T03:20:41Z